Health Policy and Management (보건행정학회지)

Korean Academy of Health Policy and Management (한국보건행정학회)
권호 표지
DOI QR코드

DOI QR Code

Korean Pharmaceutical Expenditure according to OECD's System of Health Accounts

OECD의 개념에 따른 우리나라 약제비의 국제 비교

  • 정형선 (연세대학교 보건행정학과)
  • Published : 2003.12.01
Download PDF
⟨ Previous Next ⟩

Abstract

Detailed analyses of total health expenditure and its sub­categories are essential for the evidence­based health policy(EBHP). These analyses, again, should be based on timely and reliable data that are comparable across countries. The System of Health Accounts (SHA), published by the OECD in 2000, provides an integrated system of comprehensive and internationally comparable accounts. The author has implemented the SHA manual into Korean situation, and examined overall expenditure estimate and its basic functional breakdown following the manual. This study explains how pharmaceutical expenditure is estimated. The results are, then, analyzed particularly from the international perspective. Both administrative data in Statistical Yearbooks (National Health Insurance, Medical Aid, Industrial Accident Compensation Insurance) and survey data on Health and Nutrition are used for the estimation. Per capita pharmaceutical expenditure in Korea (183 US$ PPPs) was far less than the OECD average (308 US$ PPPs) in 2001, but pharmaceutical expenditure share in total health expenditure (20.3％) was higher than the average (16.7％). This can be explained by the fact that there is a statistically significant correlation between pharmaceutical expenditure share and per capita GDP of each country. Korean people follow the tendency of relatively low­income countries to spend less than OECD average for health care, but follow again their tendency to spend more on drugs than on other health care services. In consideration of results and analysis as above, per capita pharmaceutical expenditure in Korea is expected to grow in the future, but the growth rate of the pharmaceutical expenditure is expected to be less than that of overall health expenditure.

Keywords

References

  1. 건강보험심사평가원. 요양급여비용청구내역경향조사. 서울 : 건강보험심사평가원 심사기준실 내부자료 ; 2001.
  2. 국민건강보험공단. 2001 건강보험통계연보. 서울 : 국민건강보험공단; 2002.
  3. 권순원. 국민의료비 증가추이와 안정화 방안. 서울 : 한국개발연구원; 1993.
  4. 노동부. 2001 산재보험사업연보. 서울 : 노동부; 2002.
  5. 대한약사회. 1998년도 전국 약국 경영실태조사 및 적정조제료 산출에 관한 연구보고서. 서울: 대한약사회, 1998.
  6. 박종기. 한국의 보건재정과 의료보험. 서울 : 한국개발연구원; 1979.
  7. 보건복지부. 2001 의료급여통계. 서울 : 보건복지부; 2002.
  8. 보건복지부. 2001 국민건강영양조사. 서울 : 보건복지부; 2002.
  9. 류시원, 이의경, 황인경, 박정영, 신창우, 김태현. 약국경영평가. 서울 : 한국보건사회연구원, 2001.
  10. 윤경일, 장선미. 표준약국 모형개발연구. 서울: 한국보건사회연구원, 1997
  11. 이의경, 장선미, 신종각, 박정영. 의약분업 전후의 약제비 변동요인 분석 및 정책과제. 서울: 한국보건사회연구원, 2001.
  12. 장선미, 김재용, 배은영, 구영호, 황은희, 진영란 등. 의약분업제도 성과분석 및 개선방안. 서울: 한국보건사회연구원, 2001.
  13. 장영식, 도세록, 고경환, 이래연. 국민의료비 산출체계 개발 및 추정. 서울 : 한국보건사회연구원, 2002.
  14. 정영호, 강성호. 1996년 국민의료비 추계와 지출구조 분석. 서울 : 한국보건사회연구원, 1998.
  15. 정영호, 이견직, 강성욱. 국민의료비 산출모형 개발 및 추계. 서울 : 한국보건사회연구원, 2000.
  16. 정우진, 박혜경. 의약분업 실시에 대비한 적정 의사처방료 및 약사조제료 산정 연구. 서울 : 한국보건사회연구원, 1998.
  17. 정형선, 이규식, 장영식. 보건계정의 체계 : OECE/SHA와 WHO/PG의 비교. 연세대학교보건과학연구소, 2003.
  18. 한병현. 의약분업 제도 도입에 따른 약국의 경영수지 분석 및 적정 조제료 산정 연구. 서울 : 대한약사회, 2000.
  19. Jacobzone S. Pharmaceutical Policies in OECD countries: Reconciling Social and Industrial Goals. Labour Market and Social Policy-Occasional Papers No.40, Paris : OECD; 2000.
  20. OECD. OECD Health Systems (I): Facts and Trends 1960-1991 & OECD Health Systems (II): The Socio-economic Environment Statistical References. Paris : OECD; 1993.
  21. OECD. System of Health Accounts. Paris : OECD; 2000.
  22. OECD. OECD Health Data 2003 (CD Rom). Paris : OECD; 2003a.
  23. OECD. OECD Reviews of Health Care Systems-Korea. Paris: OECD; 2003b.
  24. SNA93. System of National Accounts 1993. Brussels/Luxembourg, New York, Paris, Washington, D.C. : CEC, IMF, OECD,UN and the World Bank; 1993.